April 23, 2025

Get In Touch

Create an account to read this article

You need to create an account to read this article.

Create Account Sign in


Jubilant Pharma Develops Novel Oral Formulation Of Remdesivir, Seeks DCGI Nod For Additional Studies

0 Comments

Post a comment

Please login to post a comment.

No comments yet. Be the first to comment!